Health Condition 1: M170- Bilateral primary osteoarthritis of knee
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Primary OA Kellgren Lawrence Grade 1 -3 osteoarthritic patients. 2) Both male and female 3) Age 40-70 years 4) symptomatic disease for at least 6 months prior to enrolment 5) persistent pain despite receiving the maximal tolerated doses of conventional medical therapy
Exclusion criteria
Exclusion criteria: 1) Persons fitted with pacemaker. 2) Any prior knee surgery. 3) Persons fitted with any metallic implants. 4) Osteoarthritic patients having Kellgren Lawrence grade as 4. 5) Persons who do not provide consent for participation. 6) Presence of any medical condition that can impart effect on proposed intervention.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Both pre and post data related to pain and functionality from each and individual subjects on 1st, 5th, 15th, 30th, 45th and 60th day will be recorded using following methodologies in the experimental group (i.e., various data before and after the application of proposed medical device will be monitored): a. Pain Monitoring using Visual Analogue Scale (VAS) and Pain Pressure Threshold (PPT) device b. Functionality Monitoring using Knee Injury and Osteoarthritis Outcome Score (KOOS) and joint Angular movement measurement using Goniometers. c. Patient life style measurement using KOOS. d. Effect of Proposed PEMF device (i.e.Swaknee) on Knee Sound signals (Vibroarthrography) e. Effect of proposed device on articular (if any) using MRITimepoint: The proposed PEMF-based medical device will be applied daily to each patient in the experimental group for 45 minutes over a period of 45 days. The effects of the therapy will be assessed on the 1st, 5th, 15th, 30th, 45th, and 60th days. After completing the two-month treatment, patients will be monitored with follow-up assessments for an additional 4 months. Knee sound signals will also be collected to evaluate any changes in joint function related to the PEMF therapy. | — |
Secondary
| Measure | Time frame |
|---|---|
| To monitor the effect on articular cartilageTimepoint: 6 months | — |
Countries
India
Contacts
Swayogya Rehab Solutions Pvt Ltd